7PP1
Crystal structure of the P2Y12 receptor in complex with the inverse agonist selatogrel.
This is a non-PDB format compatible entry.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SPRING-8 BEAMLINE BL41XU |
Synchrotron site | SPring-8 |
Beamline | BL41XU |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2019-09-10 |
Detector | DECTRIS PILATUS3 6M |
Wavelength(s) | 1.000 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 98.090, 155.370, 47.310 |
Unit cell angles | 90.00, 111.48, 90.00 |
Refinement procedure
Resolution | 45.680 - 2.780 |
Rwork | 0.242 |
R-free | 0.28570 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4ntj |
RMSD bond length | 0.003 |
RMSD bond angle | 0.919 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0267) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 78.700 | 2.870 |
High resolution limit [Å] | 2.780 | 2.780 |
Number of reflections | 16554 | 1494 |
<I/σ(I)> | 18.6 | 0.6 |
Completeness [%] | 98.9 | 91.6 |
Redundancy | 50.8 | |
CC(1/2) | 0.990 | 0.500 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | LIPIDIC CUBIC PHASE | 298 | 0.1 M ammonium formate, 0.1 M sodium cacdylate, pH 6.0-6.5, 25-35% PEG400 |